Thunder Biotech

Developer of genetically engineered macrophage immunotherapy for solid tumors. This immunotherapy helps re-educate a patient's immune system, restoring its ability to recognize and destroy cancer cells. The therapy genet

placeProvo, Utah, United States calendar_todayFounded 2016 groups24 employees language thunderbiotech.com

Registered entities

Innovation

6 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 393 times.

YearFilings
20183
20193
20203
20213
20222
20241
20253

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon